Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
US6150359A · kind A · utility
7Cited by
7References
65Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2000 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | Jan 26, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the inhibition of protein tyrosine kinase (PTK) and cell cycle kinase mediated cellular proliferation. More specifically, this invention relates to naphthyridinones and their use in inhibiting cellular proliferation and PTK or cell cycle kinase enzymatic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.